The tariff classification of Doxazosin Mesylate (CAS-77883-43-3);Fluconazole (CAS-86386-73-4); Ciprofloxacin USP (CAS-85721-33-1); andFinasteride (CAS-98319-26-7), all in bulk form, from India
Reasoning
The tariff classification of Doxazosin Mesylate (CAS-77883-43-3);Fluconazole (CAS-86386-73-4); Ciprofloxacin USP (CAS-85721-33-1); andFinasteride (CAS-98319-26-7), all in bulk form, from India
Cite this ruling
CBP Ruling A89394 (2933798000): The tariff classification of Doxazosin Mesylate (CAS-77883-43-3);Fluconazole (CAS-86386-73-4); Ciprofloxacin USP (CAS-85721-33-1); andFinasteride (CAS-98319-26-7), all in bulk form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293379
The tariff classification of 2H-Azepin-2-One, 1-Ethenylhexahydro (CAS 2235-00-9) from China.
The tariff classification of 7-Fluorooxindole (CAS 71294-03-6) from France.
The tariff classification of Benazepril (CAS-86541-75-5), imported in bulk form, from China
The tariff classification of Orlistat (CAS-96829-58-2), Pramipexole (CAS-104632-26-0), Riluzole (CAS-1744-22-5), and Ropinirole Hydrochloride (CAS-91374-20-8), all imported in bulk form, from Taiwan, Spain, Spain, and Spain, respectively
The tariff classification of Megestrol Acetate (CAS-595-33-5), Clavulanate Potassium (CAS-61177-45-5), Aripiprazole (CAS-129722-12-9), and Atomoxetine Hydrochloride (CAS-82248-59-7), all imported in bulk form, from Italy, Turkey, Spain, and Italy, respectively